← Back to Search

Mental Health Support Program for Depression and Anxiety (ML-UP Trial)

N/A
Recruiting
Led By Elena L Pokowitz, M.Ed.
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

ML-UP Trial Summary

This trial seeks to provide low-cost evidence-based mental health care to those who need it most.

Who is the study for?
This trial is for undergraduate students who are at least 18 years old and interested in improving their mental health. It's not suitable for those with borderline personality disorder, active suicidal thoughts or behaviors, unwillingness to attend all sessions, non-undergraduates, or individuals experiencing active psychosis or mania.Check my eligibility
What is being tested?
The trial tests the 'Mood Lifters' program designed for undergrads to boost mental wellness. Participants will join peer-led groups aiming to reduce negative feelings like depression and anxiety while increasing pleasure and engagement through weekly meetings and support options.See study design
What are the potential side effects?
Since this intervention involves group therapy rather than medication, traditional side effects aren't expected. However, discussing sensitive topics could potentially cause discomfort or emotional distress.

ML-UP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Generalized Anxiety Disorder - 7
Patient Health Questionnaire - 9

ML-UP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
Individuals in this arm will take part in the Mood Lifters program immediately after recruitment.
Group II: Waitlist Control GroupActive Control1 Intervention
Individuals in this arm will be invited to take part in the Mood Lifters program after they complete post-treatment surveys as part of the control group.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,377,988 Total Patients Enrolled
15 Trials studying Anxiety
9,608 Patients Enrolled for Anxiety
Elena L Pokowitz, M.Ed.Principal InvestigatorUniversity of Michigan
Patricia J Deldin, Ph.D.Principal InvestigatorUniversity of Michigan

Media Library

Mood Lifters for Undergraduates Clinical Trial Eligibility Overview. Trial Name: NCT05684120 — N/A
Anxiety Research Study Groups: Treatment Group, Waitlist Control Group
Anxiety Clinical Trial 2023: Mood Lifters for Undergraduates Highlights & Side Effects. Trial Name: NCT05684120 — N/A
Mood Lifters for Undergraduates 2023 Treatment Timeline for Medical Study. Trial Name: NCT05684120 — N/A
Anxiety Patient Testimony for trial: Trial Name: NCT05684120 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment for this research endeavor still taking place?

"The information on clinicaltrials.gov demonstrates that enrollment for this trial has closed. It was initially posted on January 30th 2023, but the last update came through on January 12th 2023. Though it is not accepting patients, 1467 other studies are currently open to new participants."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Interested in finding solutions to others.
PatientReceived 1 prior treatment
~66 spots leftby Dec 2024